Click Here for 5% Off Your First Aladdin Purchase!

2-Benzylimidazoline - 97%, high purity , CAS No.59-98-3, Antagonist of α 2A-adrenoceptor;Antagonist of α 2B-adrenoceptor;Antagonist of α 2C-adrenoceptor

  • Moligand™
  • ≥97%
Item Number
B152364
Grouped product items
SKUSizeAvailabilityPrice Qty
B152364-1g
1g
In stock
$10.90
B152364-5g
5g
In stock
$38.90
B152364-25g
25g
In stock
$175.90

Basic Description

Synonymstolazoline|59-98-3|2-Benzylimidazoline|2-Benzyl-4,5-dihydro-1H-imidazole|Benzidazol|Benzazoline|2-Benzyl-2-imidazoline|Benzolin|Imidalin|Olitensol|Prefaxil|Priscoline|Vasodilatan|Artonil|Kasimid|Lambril|Priscol|Vasimid|Vasodil|Benzylimidazoline|Phenylmeth
Specifications & PurityMoligand™, ≥97%
Storage TempStore at 2-8°C,Argon charged
Shipped InWet ice
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of α 2A-adrenoceptor;Antagonist of α 2B-adrenoceptor;Antagonist of α 2C-adrenoceptor

Associated Targets

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2D6 Tclin Cytochrome P450 2D6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CNR1 Tclin Cannabinoid receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C19 Tchem Cytochrome P450 2C19 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD1 Tclin D(1A) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD2 Tclin D(2) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ESR1 Tclin Estrogen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NR3C1 Tclin Glucocorticoid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AVPR1A Tclin Vasopressin V1a receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH1 Tclin Histamine H1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A2 Tclin Sodium-dependent noradrenaline transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A3 Tclin Sodium-dependent dopamine transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A4 Tclin Sodium-dependent serotonin transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE3A Tclin cGMP-inhibited 3',5'-cyclic phosphodiesterase A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS1 Tclin Prostaglandin G/H synthase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS2 Tclin Prostaglandin G/H synthase 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD3 Tclin D(3) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1B Tclin 5-hydroxytryptamine receptor 1B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2B Tclin Alpha-2B adrenergic receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM2 Tclin Muscarinic acetylcholine receptor M2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2C Tclin Alpha-2C adrenergic receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2A Tclin 5-hydroxytryptamine receptor 2A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA2A Tclin Adenosine receptor A2a 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1B Tclin Alpha-1B adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2A Tclin Alpha-2A adrenergic receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRB1 Tclin Beta-1 adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1A Tclin Alpha-1A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAOA Tclin Amine oxidase [flavin-containing] A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1D Tclin 5-hydroxytryptamine receptor 1D 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2C Tclin 5-hydroxytryptamine receptor 2C 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA1 Tclin Adenosine receptor A1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1A Tclin 5-hydroxytryptamine receptor 1A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA3 Tchem Adenosine receptor A3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR3A Tclin 5-hydroxytryptamine receptor 3A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2B Tclin 5-hydroxytryptamine receptor 2B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EDNRA Tclin Endothelin-1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRD1 Tclin Delta-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MLNR Tchem Motilin receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-benzyl-4,5-dihydro-1H-imidazole
INCHI InChI=1S/C10H12N2/c1-2-4-9(5-3-1)8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12)
InChi Key JIVZKJJQOZQXQB-UHFFFAOYSA-N
Canonical SMILES C1CN=C(N1)CC2=CC=CC=C2
Isomeric SMILES C1CN=C(N1)CC2=CC=CC=C2
WGK Germany 3
RTECS NJ1925000
PubChem CID 5504
Molecular Weight 160.22

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

7 results found

Lot NumberCertificate TypeDateItem
G2404576Certificate of AnalysisApr 01, 2024 B152364
K2323142Certificate of AnalysisNov 28, 2023 B152364
K2323143Certificate of AnalysisNov 28, 2023 B152364
K2323144Certificate of AnalysisNov 28, 2023 B152364
K2323147Certificate of AnalysisNov 28, 2023 B152364
K2323145Certificate of AnalysisNov 27, 2023 B152364
K2323146Certificate of AnalysisNov 27, 2023 B152364

Chemical and Physical Properties

Solubilityalcohol: freely soluble; chloroform: soluble; diethyl ether: very slightly soluble;ethyl acetate: very slightly soluble;water: freely soluble
SensitivityMoisture and heat sensitive
Boil Point(°C)188 °C/20 mmHg
Melt Point(°C)66-69℃

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H302:Harmful if swallowed

H312:Harmful in contact with skin

H332:Harmful if inhaled

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P317:IF SWALLOWED: Get medical help.

P317:Get emergency medical help.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 3
RTECS NJ1925000
Merck Index 9506

Related Documents

References

1. Teskin O, Uydeş-Dogan BS, Enç Y, Alp FI, Kaleli D, Keser S, Iyigün T, Bilgen F, Dagsali S, Ozdemir O.  (2006)  Comparative effects of tolazoline and nitroprusside on human isolated radial artery..  Ann Thorac Surg,  81  (1): (125-31).  [PMID:16368348]
2. Wang S et al..  (2012)  Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation..  PLoS One,  (9): (e45499).  [PMID:23029055]
3. Deirdra Hartigan.  (2002-12-24)  Is nebulised tolazoline an effective treatment for persistent pulmonary hypertension of the newborn?.  Archives of disease in childhood,  88  ((1)): (84-84).  [PMID:12495975]
4. Todd M Delehant,Joseph W Denhart,W Eugene Lloyd,J D Powell.  (2003-09-25)  Pharmacokinetics of xylazine, 2,6-dimethylaniline, and tolazoline in tissues from yearling cattle and milk from mature dairy cows after sedation with xylazine hydrochloride and reversal with tolazoline hydrochloride..  Veterinary therapeutics : research in applied veterinary medicine,  ((2)): (128-134).  [PMID:14506588]
5. William R DuBois,Tulio M Prado,Jeff C H Ko,Ronald E Mandsager,Gregor L Morgan.  (2004-04-01)  A comparison of two intramuscular doses of xylazine-ketamine combination and tolazoline reversal in llamas..  Veterinary anaesthesia and analgesia,  31  ((2)): (90-96).  [PMID:15053746]
6. Hanno Huwer,J Winning,U Straub,H Isringhaus,G Kalweit.  (2004-07-14)  Clinically diagnosed nonocclusive mesenteric ischemia after cardiopulmonary bypass: retrospective study..  Vascular,  12  ((2)): (114-120).  [PMID:15248641]
7. Anne Greenough,Ashok Pulikot,Gabriel Dimitriou.  (2005-02-26)  Prevention and management of meconium aspiration syndrome--assessment of evidence based practice..  European journal of pediatrics,  164  ((5)): (329-330).  [PMID:15731907]
8. Enrique M Ostrea,Esterlita T Villanueva-Uy,Girija Natarajan,Herbert G Uy.  (2006-06-16)  Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management..  Paediatric drugs,  ((3)): (179-188).  [PMID:16774297]
9. Richard N Loeppky,Jianzheng Shi.  (2008-02-01)  N-nitrosotolazoline: decomposition studies of a typical N-nitrosoimidazoline..  Chemical research in toxicology,  21  ((2)): (308-318).  [PMID:18232661]
10. Tulio M Prado,William R DuBois,Jeff C H Ko,Ronald E Mandsager,Gregor L Morgan.  (2008-02-20)  A comparison of two combinations of xylazine-ketamine administered intramuscularly to alpacas and of reversal with tolazoline..  Veterinary anaesthesia and analgesia,  35  ((3)): (201-207).  [PMID:18282257]
11. Daisuke Yoshida,Hiroaki Todo,Tetsuya Hasegawa,Kenji Sugibayashi.  (2008-02-26)  Effect of vasoactive agents on the dermatopharmacokinetics and systemic disposition of model compounds, salicylate and FITC-dextran 4 kDa, following intracutaneous injection of the compounds..  International journal of pharmaceutics,  356  ((1-2)): (181-186).  [PMID:18294788]
12. C D Contreras,A E Ledesma,J Zinczuk,S A Brandán.  (2011-06-15)  Vibrational study of tolazoline hydrochloride by using FTIR-Raman and DFT calculations..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  79  ((5)): (1710-1714).  [PMID:21664861]
13. Terry J Kreeger,Kalin A Kellie.  (2012-10-13)  Sufentanil citrate immobilization of Alaskan moose calves..  Journal of wildlife diseases,  48  ((4)): (1088-1091).  [PMID:23060515]
14. Shin-ichi Yokota,Yoshiaki Hikasa,Itsumi Shimura,Shuei Kusunose.  (2013-02-27)  Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets..  American journal of veterinary research,  74  ((3)): (395-402).  [PMID:23438114]
15. Aurélie Periat,Isabelle Kohler,Aurélie Bugey,Stefan Bieri,François Versace,Christian Staub,Davy Guillarme.  (2014-07-16)  Hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry: effect of electrospray ionization source geometry on sensitivity..  Journal of chromatography. A,  1356  (211-220).  [PMID:25017394]
16. Charlene Galea,Debby Mangelings,Yvan Vander Heyden.  (2015-01-30)  Method development for impurity profiling in SFC: The selection of a dissimilar set of stationary phases..  Journal of pharmaceutical and biomedical analysis,  111  (333-343).  [PMID:25630237]
17. Timothy M Martin,Sarah A Plautz,Angela K Pannier.  (2015-02-11)  Temporal endogenous gene expression profiles in response to polymer-mediated transfection and profile comparison to lipid-mediated transfection..  The journal of gene medicine,  17  ((1-2)): (33-53).  [PMID:25663627]
18. Aaron D Gross,Kevin B Temeyer,Tim A Day,Adalberto A Pérez de León,Michael J Kimber,Joel R Coats.  (2015-05-11)  Pharmacological characterization of a tyramine receptor from the southern cattle tick, Rhipicephalus (Boophilus) microplus..  Insect biochemistry and molecular biology,  63  (47-53).  [PMID:25958152]
19. Slavica Filipic,Aleksandra Antic,Milena Vujovic,Katarina Nikolic,Danica Agbaba.  (2016-07-14)  A Comparative Study of Chromatographic Behavior and Lipophilicity of Selected Imidazoline Derivatives..  Journal of chromatographic science,  54  ((7)): (1137-1145).  [PMID:27406126]
20. P Cagnardi,R Villa,G Ravasio,L Lucatello,F Di Cesare,F Capolongo,A Boccardo,D Pravettoni.  (2016-09-20)  Pharmacokinetics and sedative effects of dexmedetomidine in dairy calves..  New Zealand veterinary journal,  65  ((1)): (14-18).  [PMID:27643584]
21. Yi-Xiang Qi,Gang Xu,Gui-Xiang Gu,Fen Mao,Gong-Yin Ye,Weiwei Liu,Jia Huang.  (2017-09-26)  A new Drosophila octopamine receptor responds to serotonin..  Insect biochemistry and molecular biology,  90  (61-70).  [PMID:28942992]
22. Qi Yan,David Machalz,Andy Zöllner,Erik J Sorensen,Gerhard Wolber,Matthias Bureik.  (2017-09-28)  Efficient substrate screening and inhibitor testing of human CYP4Z1 using permeabilized recombinant fission yeast..  Biochemical pharmacology,  146  (174-187).  [PMID:28951277]
23. A Rolle,S Paredes,L I Cortínez,B J Anderson,N Quezada,S Solari,F Allende,J Torres,D Cabrera,V Contreras,J Carmona,C Ramírez,A M Oliveros,M Ibacache.  (2018-04-18)  Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients..  British journal of anaesthesia,  120  ((5)): (969-977).  [PMID:29661414]
24. Ming Yang,Chunye Zhang,Sarah A Hansen,William J Mitchell,Michael Z Zhang,Shuping Zhang.  (2019-12-18)  Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model..  BMC microbiology,  19  ((1)): (293-293).  [PMID:31842727]
25. Christine R Casey,Wendy C Andersen,Nicole T Williams,Tara J Nickel,Patrick R Ayres.  (2020-05-01)  Multiclass, Multiresidue Method for the Quantification and Confirmation of 112 Veterinary Drugs in Game Meat (Bison, Deer, Elk, and Rabbit) by Rapid Polarity Switching Liquid Chromatography-Tandem Mass Spectrometry..  Journal of agricultural and food chemistry,  69  ((4)): (1175-1186).  [PMID:32352772]
26. Beulah Leitch,Sarah Judge,Robert M Pitman.  (2003-05-23)  Octopaminergic modulation of synaptic transmission between an identified sensory afferent and flight motoneuron in the locust..  The Journal of comparative neurology,  462  ((1)): (55-70).  [PMID:12761824]
27. Beate Maria Stoeckelhuber,Ingo Suttmann,Mechthild Stoeckelhuber,Georg Kueffer.  (2003-06-21)  Comparison of the vasodilating effect of nitroglycerin, verapamil, and tolazoline in hand angiography..  Journal of vascular and interventional radiology : JVIR,  14  ((6)): (749-754).  [PMID:12817042]
28. Brad F Miller,Lisa I Muller,Tom Doherty,David A Osborn,Karl V Miller,Robert J Warren.  (2004-10-07)  Effectiveness of antagonists for tiletamine-zolazepam/xylazine immobilization in female white-tailed deer..  Journal of wildlife diseases,  40  ((3)): (533-537).  [PMID:15465721]
29. Anne Greenough,Babita Khetriwal.  (2005-05-25)  Pulmonary hypertension in the newborn..  Paediatric respiratory reviews,  ((2)): (111-116).  [PMID:15911456]
30. J A E Hubbell,W W Muir.  (2006-05-19)  Antagonism of detomidine sedation in the horse using intravenous tolazoline or atipamezole..  Equine veterinary journal,  38  ((3)): (238-241).  [PMID:16706278]
31. Richard N Loeppky,Jianzheng Shi.  (2008-02-01)  Nucleoside and DNA adducts from N-nitrosotolazoline..  Chemical research in toxicology,  21  ((2)): (319-329).  [PMID:18232662]
32. Christof M Sommer,Boris A Radeleff.  (2009-01-22)  A novel approach for percutaneous treatment of massive nonocclusive mesenteric ischemia: tolazoline and glycerol trinitrate as effective local vasodilators..  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,  73  ((2)): (152-155).  [PMID:19156878]
33. Jia Huang,Tomohiro Hamasaki,Yoshihisa Ozoe.  (2009-11-18)  Pharmacological characterization of a Bombyx mori alpha-adrenergic-like octopamine receptor stably expressed in a mammalian cell line..  Archives of insect biochemistry and physiology,  73  ((2)): (74-86).  [PMID:19918790]
34. Kohji Takara,Kazuhiro Yamamoto,Mika Matsubara,Tetsuya Minegaki,Minoru Takahashi,Teruyoshi Yokoyama,Katsuhiko Okumura.  (2012-02-23)  Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport..  PloS one,  ((2)): (e30697-e30697).  [PMID:22355323]
35. Jack Alan Mortenson,Jason Andrew Robison.  (2011-03-01)  Tolazoline-induced apnea in mule deer (Odocoileus hemionus)..  Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,  42  ((1)): (105-107).  [PMID:22946377]
36. Hilmi Islami,Arta Veseli,Emir Behluli,Naim Morina.  (2012-10-27)  Importance of the adrenergic nerve system in the response of gases in the arterial blood following the provoked bronchospasm..  Medical archives (Sarajevo, Bosnia and Herzegovina),  66  ((5)): (292-295).  [PMID:23097963]
37. Leonardo Gentile,Menzano Arianna,Latini Roberta,Mari Franco,Rossi Luca.  (2015-06-10)  IMMOBILIZING THE VULNERABLE APENNINE CHAMOIS (RUPICAPRA PYRENAICA ORNATA) WITH A LOW-DOSE XYLAZINE-KETAMINE COMBINATION, REVERSED WITH IDAZOXAN OR ATIPAMEZOLE..  Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,  46  ((2)): (213-223).  [PMID:26056871]
38. Luis I Cortínez,Brian J Anderson,Nick H G Holford,Valentina Puga,Natalia de la Fuente,Hernán Auad,Sandra Solari,Fidel A Allende,Mauricio Ibacache.  (2015-09-27)  Dexmedetomidine pharmacokinetics in the obese..  European journal of clinical pharmacology,  71  ((12)): (1501-1508).  [PMID:26407689]
39. Rachel Reed,Michele Barletta,Janet Grimes,Jennifer Mumaw,Hea Jin Park,Steeve Giguère,Michael Azain,Xi Fang,Jane Quandt.  (2018-03-22)  Accuracy of an oscillometric blood pressure monitor in anesthetized pigs..  Laboratory animals,  52  ((5)): (490-496).  [PMID:29558859]

Solution Calculators